Gilead, Goldfinch to team up against kidney disease
The multi-year collaboration will expand the scope of Goldfinch’s proprietary Kidney Genome Atlas.
Read More
Tag: Goldfinch
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
